RudaCure Inc., una bioventure dirigida a canales iónicos especializada en el desarrollo de nuevos fármacos, donated 1 ton of feed to a local stray animal shelter at the end of the year, demonstrating its commitment to community apoyo.
RudaCure anunció el 29th that it delivered 1 ton of cat-specific feed to 'Sansu Angels,' a stray animal shelter located in Namdong-gu, Incheon. This donation fue llevado a cabo as part of la empresa's second-half 2025 corporate social responsibility activities.
What makes this donation particularly meaningful is that it fue llevado a cabo after carefully assessing the shelter's actual needs. While dog food donations are relatively common, cat food is known to be in comparatively short supply. RudaCure reportedly identified these on-site challenges through preliminary investigación and decided to provide the much-needed cat food apoyo.
A representative from 'Sansu Angels' expresó gratitude, saying, "Dog food donations are always plentiful, but cat food donations are relatively rare, making it difficult to secure enough feed during winter. Since they are a company that also develops animal pharmaceuticals, they precisely understood what our shelter needs and prepared food specifically for our cats, which will help us get through the cold winter."
RudaCure es una empresa biotecnológica que desarrolla productos farmacéuticos tanto humanos como veterinarios. The selección of this particular shelter and the type of donation appear to han sido driven by la empresa's understanding of and interest in animal health.
Members of RudaCure's Efficacy Research Team who participó in the donation event dijo, "We are delighted to provide practical help to facilities in need in our local community," adding, "Continuaremos carry out various CSR activities en el futuro."
Un observador de la industria señaló: "As gestión ESG practices expand among bio-empresas farmacéuticas, more cases like RudaCure's are emerging—going beyond simple donations to providing customized apoyo based on actual field needs. It is particularly noteworthy that a company developing animal pharmaceuticals is taking interest in and acting on stray animal welfare, serving as a great example of connecting business with social contribution."
RudaCure es una empresa bioventure que desarrolla fármacos innovadores para humanos y animales based on its proprietary drug plataforma that modulates the TRPV1 (Transient Receptor Potential Vanilloid 1) canal iónico. La empresa promotes sustainable management through various ESG activities, including community contributions and employee volunteer programas alongside business crecimiento.
Earlier en el primer semestre de the year, RudaCure realizó an employee blood donation campaign and plogging (environmental cleanup) activities, and in the segundo semestre amplió its social contribution scope to include stray animal welfare apoyo. La empresa stated that it planea continuar various volunteer activities and donations in colaboración with the local community in 2026.
